What type of study is this?

This is a RCT study (also classified as: Human Clinical Trial).

Driving performance in the morning after bedtime vornorexant administration: A randomized clinical trial using a driving simulator

View Full Paper

Ask AI

Bookmark

No clinically meaningful impairment in driving performance was observed after vornorexant administration.
Mean change in standard deviation of lateral position was minimal for both doses of vornorexant on Day 2 and Day 9.
Comparative analysis included zopiclone, which showed larger impairments with mean changes of approximately 6 cm.
Consistent pharmacokinetics were recorded across single and repeated dosing, ensuring reliability of results.

No takes yet. Share an insight, caveat, or question.

Randomized clinical trial assessed the effect of vornorexant on driving performance in healthy participants, indicating no significant impairment.

Miyazaki et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Randomized clinical trial assessed the effect of vornorexant on driving performance in healthy participants, indicating no significant impairment.